Evidence map›Paper›PMID 32597807›Full record

ArticleJournal of Alzheimer's disease : JAD2020

Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer's Disease Dementia via Lead-Lag Analysis.

Manuel Fuentes, Arne Klostermann, Luca Kleineidam, Chris Bauer, Johannes Schuchhardt, Wolfgang Maier, Frank Jessen, Lutz Frölich, Jens Wiltfang, Johannes Kornhuber and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Manuel FuentesCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health (BIH), Department of Psychiatry, Berlin, Germany.
Arne KlostermannCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health (BIH), Department of Psychiatry, Berlin, Germany.
Luca KleineidamDepartment of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn, Germany.
Chris BauerMicroDiscovery GmbH, Berlin, Germany.
Johannes SchuchhardtMicroDiscovery GmbH, Berlin, Germany.
Wolfgang MaierDepartment of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.
Frank JessenDepartment of Psychiatry, University of Cologne, Medical Faculty, Cologne, Germany.
Lutz FrölichDepartment of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Jens WiltfangDepartment of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.
Johannes KornhuberDepartment of Psychiatry and Psychotherapy, Friedrich-Alexander-University of Erlangen-Nuremberg, Nuremberg, Germany.
Stefan KlöppelDepartment of Psychiatry and Psychotherapy, University of Freiburg, Freiburg, Germany.
Vera SchietingDepartment of Psychiatry and Psychotherapy, University of Freiburg, Freiburg, Germany.
Stefan J TeipelGerman Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
Michael WagnerDepartment of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn, Germany.
Oliver PetersCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health (BIH), Department of Psychiatry, Berlin, Germany.
German Center for Neurodegenerative Diseases · DEUniversity of Bonn · DEMicroDiscovery (Germany) · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEHeidelberg University · DEHumboldt-Universität zu Berlin · DEUniversity of Bern · CHUniversity of Cologne · DEUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCognitive functions and activities of daily living (ADL) become increasingly impaired with progressing Alzheimer's disease. However, the temporal dynamics of this decline are inconsistent.

objectiveTo gain insight into the classical temporal cascade of specific cognitive and ADL changes, which may aid in improving detection of an impending clinical deterioration in patients, and to select ADL items and tests most sensitive to change in a specific disease stage.

methodsPatients with mild Alzheimer's dementia (AD; MMSE = 23.9±2.88) were followed at 12 and 24 months. Lead-lag analysis of changes in cognitive and functional outcome measures (CDR-SOB, 12 neuropsychological subtest scores from the CERAD + test battery, 25 Bayer-ADL items) was applied to rank the temporal sequence of changes on an ordinal scale.

resultsOf 164 patients with mild AD, moderate disease progression was identified in 84 patients over 24 months (ΔMMSE 5.8±8.64; ΔCDR-SOB 4.32±4.03). Ten Bayer-ADL item measures were altered early in moderate progressors and included in a new ADL composite score. Accordingly, the new ADL score surpassed all neuropsychological measures in repeated lead-lag analysis. The Bayer-ADL total score, TMT-A, and MMSE were lagging variables in all lead-lag analyses.

conclusionShort-term clinical deterioration in mild AD is initially preceded by changes (i.e., decline) in a well-defined set of ADL and not in classical cognitive measures.

Indexed as

Clinical DeteriorationActivities of Daily LivingAgedAlzheimer DiseaseCognitionDisease ProgressionFemaleHumansMaleNeuropsychological TestsTime FactorsAlzheimer’s diseasebayer activities of daily living scalecognitive changesdisease progressionfunctional changeslead and lag analysis

Identifiers

PMID32597807
PMCPMC7504993
OpenAlexW3037004389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.